CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 93 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $375,000 | -3.8% | 31,092 | 0.0% | 0.00% | -100.0% |
| Q4 2018 | $390,000 | -0.8% | 31,092 | +17.4% | 0.00% | – |
| Q3 2018 | $393,000 | -11.9% | 26,492 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $446,000 | -26.5% | 26,492 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $607,000 | -15.6% | 26,492 | -4.7% | 0.00% | 0.0% |
| Q4 2017 | $719,000 | +75.4% | 27,792 | 0.0% | 0.00% | – |
| Q3 2017 | $410,000 | +5.7% | 27,792 | 0.0% | 0.00% | – |
| Q2 2017 | $388,000 | -18.1% | 27,792 | 0.0% | 0.00% | -100.0% |
| Q1 2017 | $474,000 | +65.7% | 27,792 | 0.0% | 0.00% | – |
| Q4 2016 | $286,000 | +1.8% | 27,792 | 0.0% | 0.00% | – |
| Q3 2016 | $281,000 | -9.9% | 27,792 | 0.0% | 0.00% | -100.0% |
| Q2 2016 | $312,000 | -10.3% | 27,792 | +5.7% | 0.00% | 0.0% |
| Q1 2016 | $348,000 | +22.1% | 26,292 | +75.3% | 0.00% | 0.0% |
| Q4 2015 | $285,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,135,289 | $46,246,000 | 5.88% |
| GREAT POINT PARTNERS LLC | 2,006,211 | $29,592,000 | 5.76% |
| Lyon Street Capital, LLC | 463,064 | $6,830,000 | 2.63% |
| SENZAR ASSET MANAGEMENT, LLC | 335,445 | $4,948,000 | 1.21% |
| INGALLS & SNYDER LLC | 1,209,062 | $17,834,000 | 0.93% |
| Senvest Management, LLC | 314,629 | $4,641,000 | 0.31% |
| KNOTT DAVID M | 45,000 | $664,000 | 0.28% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 262,569 | $3,873,000 | 0.15% |
| PRINCETON CAPITAL MANAGEMENT INC | 14,607 | $215,000 | 0.11% |
| Manchester Capital Management LLC | 19,984 | $295,000 | 0.05% |